Agouron Institute

Recent papers from Agouron Institute

1. Lonigutamab inhibits hyaluronan production by reducing IGF-1R levels in thyroid eye disease orbital fibroblastsThe Journal of Clinical Endocrinology & Metabolism · 2026
2. IV-EVE: EVE for Injection—ADME, Pharmacokinetic and Toxicological Evaluation for Novel Deciparticle EVE FormulationBiomedicines · 2026
3. Sub-15 nm Nanoparticles for Drug Delivery: Emerging Frontiers and Therapeutic PotentialInternational Journal of Molecular Sciences · 2025
4. Sub-15 nm Nanoparticles for Drug Delivery: Emerging Frontiers and Therapeutic PotentialInternational Journal of Molecular Sciences · 2025
5. Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 studyAnnals of the Rheumatic Diseases · 2025
6. NOT gated T cells that selectively target EGFR and other widely expressed tumor antigensiScience · 2024
7. JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published LiteratureCancers · 2024
8. Bacterial Quorum Sensing: The Most Ancient Language on EarthFrontiers for Young Minds · 2023
9. Utilizing Super-Resolution for Enhanced Automotive Radar Object Detection2023
10. Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasismAbs · 2023
11. Data from Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity2023
12. An Application that Combines Learning and Games to Make Learners Keep Interested in Learning2023
13. The rate, cost and outcomes of parathyroidectomy in the united states dialysis population from 2016–2018BMC Nephrology · 2022
14. A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivoScience Translational Medicine · 2022
15. A rational approach to assess off-target reactivity of a dual-signal integrator for T cell therapyToxicology and Applied Pharmacology · 2022
16. Abnormal CD8 T cells induce and track Alzheimer’s-like neurodegeneration2021
17. Targeting TGF-β pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal Accelerates Recovery from Mild-Moderate COVID-192021
18. The ELFIN MissionSpace Science Reviews · 2020
19. Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectivesInternational Journal of Nanomedicine · 2019
20. Efficacy and safety of Eurycoma longifolia (Physta®) water extract plus multivitamins on quality of life, mood and stress: a randomized placebo-controlled and parallel studyFood & Nutrition Research · 2018